Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PARP Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05551208
What this trial is testing

Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi

Who this might be right for
Ovarian Cancer
Chongqing University Cancer Hospital 42
Testing effectiveness (Phase 2)UnknownNCT05475184
What this trial is testing

Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor

Who this might be right for
Ovarian Cancer
Onconic Therapeutics Inc. 58
Large-scale testing (Phase 3)Study completedNCT01847274
What this trial is testing

A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsPlatinum Sensitive Ovarian Cancer
Tesaro, Inc. 596
Early research (Phase 1)Active Not RecruitingNCT05787587
What this trial is testing

PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsBreast CancerOvarian Cancer+6 more
IDEAYA Biosciences 216
Testing effectiveness (Phase 2)Looking for participantsNCT04901702
What this trial is testing

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Who this might be right for
Recurrent Solid TumorRecurrent Ewing SarcomaRecurrent Hepatoblastoma+19 more
St. Jude Children's Research Hospital 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05366166
What this trial is testing

Pembrolizumab Plus Olaparib in LA-HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
UNC Lineberger Comprehensive Cancer Center 45
Early research (Phase 1)Looking for participantsNCT05870423
What this trial is testing

Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors

Who this might be right for
Neuroendocrine TumorsPeptide Receptor Radionuclide Therapy
Erasmus Medical Center 24
Early research (Phase 1)WithdrawnNCT05262842
What this trial is testing

JS001+IMP4297 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
Testing effectiveness (Phase 2)UnknownNCT05489926
What this trial is testing

Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure

Who this might be right for
Epithelial Ovarian Cancer
Zhejiang Cancer Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT06441747
What this trial is testing

Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

Who this might be right for
Cholangiocarcinoma
Australasian Gastro-Intestinal Trials Group 40
Large-scale testing (Phase 3)Ended earlyNCT03642132
What this trial is testing

Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)

Who this might be right for
Ovarian Cancer
Pfizer 79
Testing effectiveness (Phase 2)Looking for participantsNCT05538091
What this trial is testing

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal CarcinomaPARP Inhibitor+1 more
Ronald Buckanovich 48
Testing effectiveness (Phase 2)Study completedNCT03462342
What this trial is testing

Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer

Who this might be right for
High Grade Serous Carcinoma
University of Pennsylvania 123
Testing effectiveness (Phase 2)Ended earlyNCT05501548
What this trial is testing

Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Testing effectiveness (Phase 2)Looking for participantsNCT05700721
What this trial is testing

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Who this might be right for
Brain Metastases
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Looking for participantsNCT05894018
What this trial is testing

Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma

Who this might be right for
Sarcoma,Soft TissueBrachytherapyPoly(ADP-ribose) Polymerase Inhibitors
Fujun Zhang 32
Early research (Phase 1)Study completedNCT00553189
What this trial is testing

Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas

Who this might be right for
Solid TumorsLymphomas
National Cancer Institute (NCI) 31
Early research (Phase 1)Looking for participantsNCT06545942
What this trial is testing

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorProstate Cancer+4 more
MOMA Therapeutics 220
Large-scale testing (Phase 3)Looking for participantsNCT07472140
What this trial is testing

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer
N.N. Alexandrov National Cancer Centre 120
Early research (Phase 1)Study completedNCT03954366
What this trial is testing

Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives

Who this might be right for
Neoplasms
pharmaand GmbH 36
Next Page